节点文献

HBeAg阴性慢性乙型肝炎和乙型肝炎肝硬化临床特点分析

Clinical features of patients with HBeAg-negative chronic hepatitis B and HBV-related cirrhosis

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 贾莹徐京杭王军斯崇文于岩岩

【Author】 JIA Ying,XU Jing-hang,WANG Jun,SI Chong-wen,YU Yan-yan * Department of Infectious Diseases,Peking University First Hospital,Beijing 100034,China

【机构】 北京大学第一医院感染疾病科

【摘要】 目的了解HBeAg阴性慢性乙型肝炎(乙肝)及乙肝肝硬化患者的临床特点,为防治方案的制定提供依据。方法回顾性分析673例于我科住院的慢性乙肝及乙肝肝硬化患者临床资料,根据HBeAg特点分为阴性组和阳性组,分析2组患者年龄、病程、病毒学等方面的异同。结果阴性组352例,占52.3%;阳性组321例,占47.7%。阴性组患者入院时平均年龄较阳性组患者大[(51.2±13.0)、(40.8±14.1)岁,P=0.000]、HBsAg阳性持续时间长[12.0(0.5,59.0)、6.0(0.5,48.0)年,P=0.000]、血清HBVDNA载量低[1.01菖10(4<103,4.91菖108)、1.30菖10(6<103,7.11菖109)copies/ml,P=0.000],2组患者血清HBsAg定量差异无统计学意义[3685(1,9090)和3530(2,10600)U/ml,P=0.271]。阴性组并发原发性肝癌的发生率较HBeAg阳性组高(20.5%和8.7%,P=0.000)。结论在我科住院的慢性乙肝和乙肝肝硬化患者中,HBeAg阴性患者占相当的比例,HBeAg阴性患者年龄大、病史长、血清HBVDNA载量较低,并发原发性肝癌多见。

【Abstract】 Objective To investigate clinical features of patients with HBeAg-negative chronic hepatitis B(CHB) and HBV-related cirrhosis and to provide evidence for the prevention and treatment protocols.Methods A retrospective study was conducted on 673 inpatients with CHB and HBV-related cirrhosis,who were treated in our department.According to HBeAg status,all the pa-tients were divided into 2 groups,HBeAg-negative group and HBeAg-positive group.Age,duration of disease and virological features were compared between the 2 groups.Results A total of 352 patients(52.3%) were HBeAg negative and 321(47.7%) were HBeAg positive.The mean age in HBeAg-negative group was(51.2±13.0) years old,older than that in HBeAg-positive group [(40.8±14.1) years old] when they were admitted to hospital(P=0.000).The duration of HBsAg positive in HBeAg-negative group was 12.0(0.5,59.0) years,longer than that in HBeAg-positive group [6.0(0.5,48.0) years](P=0.000).The median serum HBV DNA level in HBeAg-neg-ative group was 1.01×10 4(<10 3,4.91×10 8) copies/ml,lower than that in HBeAg-positive group [1.30×10 6(<10 3,7.11×10 9) copies/ml](P=0.000).The median serum HBsAg levels were 3685(1,9090) U/ml in HBeAg-negative group and 3530(2,10 600) U/ml in HBeAg-positive group,and the difference between them was not significant(P=0.271).About 20.5% of HBeAg-negative patients developed primary liver cancer,and the proporation was higher than that of HBeAg-positive patients(8.7%)(P=0.000).Conclusions Of pa-tients with CHB and HBV-related cirrhosis admitted to our hospital,HBeAg-negative patients account for a substantial proportion.They are much older,have longer duration of disease and lower serum HBV DNA level,and more commonly develop primary liver cancer.

【关键词】 肝炎,乙型,慢性肝硬化HBeAgHBVDNA
【Key words】 hepatitis B,chronicliver cirrhosisHBeAgHBV DNA
【基金】 国家“十一五”科技重大专项(2008ZX10002-004)
  • 【文献出处】 传染病信息 ,Infectious Disease Information , 编辑部邮箱 ,2011年03期
  • 【分类号】R512.62
  • 【被引频次】11
  • 【下载频次】184
节点文献中: 

本文链接的文献网络图示:

本文的引文网络